“…Biologic activity has been attributed to almost all of these P450 derivatives, which, just like the EETs, are reported to activate large-conductance calcium-activated potassium (BK) channels, leading to the hyperpolarization and relaxation of vascular smooth muscle cells (VSMCs) (Lauterbach et al, 2002;Ye et al, 2002;Morin et al, 2009). Moreover, the EEQs and EDPs demonstrate cardiovascular-protective properties, have been linked with angiogenesis and improved wound healing (Liclican and Gronert, 2010;Tian et al, 2010), and also show antihypertensive, antithrombotic, and antiatherosclerotic effects in several rat models (McLennan et al, 1996;Hashimoto et al, 1999;Frenoux et al, 2001). However, the specific enzymes involved in the conversion of linoleic acid, EPA, and DPA are less well studied than those that metabolize arachidonic acid, especially in relation to their effects on cardiovascular homeostasis (Oliw et al, 1996;Bylund et al, 1998a,b) and EPA and DPA "antagonists" have not been widely tested.…”